Wegovy could make history again Wegovy made history this year when it slashed the risk of serious heart problems by 20% in people with obesity and heart disease in a late-stage trial
TB-500 (thymosin 4) drives systemic cell migration and angiogenesis, accelerating endothelial migration several-fold in preclinical research[2]
Readers should be wary of dramatic social media claims, especially those promising major fat loss within 24 hours
Cardiovascular safety of antidiabetic medications has received increasing attention since 2008 and here we summarize the recent updates from both clinical trials and preclinical experiments on the cardiovascular outcomes of this class of glucose-lowering drugs
Spreading Awareness Through Visual Appeal The colorful branding of World Oral Health Day extends to various resources provided by the organizers, including posters, social media content, and activity sheets
Some people find that even a moderate serving of watermelon feels heavy or creates nausea because the medication enhances their internal awareness of fullness